National Medicines Symposium 2016: speakers
Dr Sue Andrews
Dr Sue Andrews is a member of the Health Care Consumers Association of the ACT and President of the HCCA Executive Committee. She is a consumer representative on a number of quality and safety committees in the ACT Health system. Sue has worked in different roles in the health field including clinical, research and policy areas as well as the non-government sector. As a consumer she is committed to, and values, consumer health partnerships that are central to the development, planning and delivery of safe, accessible and equitable health care services.
Gold Walkley Award-winning journalist, MC & Facilitator
Monica Attard was one of the ABC's most senior journalists, after a 28-year career with the national broadcaster. She served the corporation overseas and presented some of its most high profile current affairs programs.
Monica was awarded two Walkley Awards for Best Broadcast Interviewing for her work on Sunday Profile, bringing her total Walkley count to five. In 2006 she was appointed host of Media Watch on ABC TV and she returned for a second season in 2007.
She has a law degree and is the creator and former Managing Editor of The Global Mail.
Monica is now working with CNN International, based in Sydney.
Arrangements for Monica Attard’s involvement in NMS 2016 were made through Celebrity Speakers – www.celebrityspeakers.com.au
Assoc Prof Jane Burns
Associate Professor Jane Burns is the founder and CEO of the Young and Well Cooperative Research Centre, an organisation that unites young people with researchers, practitioners and innovators to explore the role of technology in improving mental health and wellbeing for young people aged 12 to 25.
Jane holds a Principal Research Fellowship at Orygen, The National Centre of Excellence in Youth Mental Health and an Honorary Fellowship at the Brain & Mind Centre. She has led the youth agenda for beyondblue, was a Commonwealth Fund Harkness Fellow at the University of California, San Francisco, and was Director of International Partnerships at Inspire Foundation. Jane held a VicHealth fellowship from 2006-2013, an NHMRC fellowship from 1997-2000 and an NHMRC scholarship from 1994-1996. She holds a PhD in Medicine from the Faculty of Medicine (Public Health and Epidemiology) University of Adelaide.
Jane was recently announced a winner in the category of Social Enterprise and Not-for-profit for 2015’s Australian Financial Review and Westpac Group 100 Women of Influence, and was a Victorian Finalist in the 2012 Telstra Business Women's Awards. Jane is a Graduate of the Australian Institute of Company Directors.
Dr Bruce Carleton
Professor of Paediatrics and Chair of the Division of Translational Therapeutics, Department of Pediatrics at the University of British Columbia.
Dr. Carleton is also Senior Clinician Scientist at the Child & Family Research Institute. He directs the Pharmaceutical Outcomes Programme at BC Children’s Hospital and he has served in this capacity since 1994.
Dr. Carleton’s lifelong goal is to make medication use more effective and safer for all patients, particularly children. His research focus is on the impact of drug therapy on human health and quality of life. He is particularly interested in developing better ways to evaluate the effectiveness of drugs, medication-use models designed to improve patient health, as well as practical surveillance systems to improve the safe use of medication.
Ms Amy Cordorey
Amy Corderoy is an award-winning health journalist, and the former health editor of the Sydney Morning Herald. She has a passion for evidence-based medicine, believing it to be one of the most important issues facing the healthcare sector today.
Among numerous other appointments she has written for the Guardian, SBS, Crikey and Australian Doctor, as well as contributing a chapter to The Curious Country, a book released by the Chief Scientist of Australia.
In December last year she left the Herald to begin a postgraduate medicine degree at the University of Notre Dame Australia’s Sydney campus, where she is currently learning to palpate, percuss and practice what she preaches when it comes to evidence-based medicine.
Dr Rachel David
Dr Rachel David is an expert on healthcare policy and financing, with a special interest in evidence-based medicine. She is passionate about harnessing medical best practice and policy to improve health outcomes in the community.
In the current role of CEO of Private Healthcare Australia, Dr David undertakes policy and advocacy work, as well as thought leadership for Australia’s major health funds. Previous roles include senior adviser to the Federal Minister for Health, Director of Government Relations and Market Access for the Johnson & Johnson Family and founding practice manager of the healthcare and Australian government sector practice at McKinsey & Company. Formerly a medical practitioner, Rachel has worked in public hospital administration and management.
Ms Clare Duffy
Claire is Principal at Speak for Yourself, working with individuals and organisations who want to develop the skills of thinking, planning, communicating, speaking and presenting well. Claire has a background in strategic communications with over 25 years in leadership roles in arts and cultural organisations, schools, professional services, non-profits and government. She is a highly experienced debate co-ordinator and is the author of The Australian Schoolkids Guide to Debating and Public Speaking.
Dr Tony Gill
Dr Tony Gill is a public health physician who joined the Therapeutic Goods Administration (TGA) in February 2010. Dr Gill’s experience in the TGA has included overseeing access to unapproved therapeutic goods and the scheduling of medicines. Since May 2015 Dr Gill has been acting Principal Medical Adviser for the TGA.
Dr Stefan Hajkowicz
Dr Stefan Hajkowicz is a senior principal scientist working in the field of strategic foresight at Data61 | CSIRO.
Stefan’s research and consulting work helps companies, governments and communities explore plausible futures and make wise strategic choices. He is increasingly focused on the strategic implications of digital technology.
Stefan is a world leading scholar in the field of decision theory and has published seminal works on the use multi-objective decision support. His research has contrasted structured versus intuitive approaches to decision making. His decision models have guided investments worth hundreds of millions of dollars and have been used by Australia’s State and Federal Governments to make critical policy choices.
Stefan is widely published in the international scientific literature and his most recent book titled “Global Megatrends” is available through CSIRO Publishing.
Dr Steve Hambleton
As the Australian Medical Association’s former federal president, Dr Steve Hambleton’s face is one of the most recognised faces in Australia yet few know of him beyond medico-politics. Steve graduated from the University of Queensland in 1984 and commenced full-time general practice in Queensland in 1987. He has worked at the same general practice in suburban Brisbane since 1988. A father of four, he has particular interests in primary health care, Indigenous health, medical training and clinical engagement.
Stephen Jan is the Head of the Health Economics and Process Evaluation program at the George Institute for Global Health, Professor of Health Economics at the Sydney Medical School, University of Sydney. He was awarded his PhD at Sydney University and has previously held positions at the London School of Hygiene and Tropical Medicine and the Centre for Health Economics Research and Evaluation, Sydney. He conducts research in Australia and many low and middle income countries with specific interests in equity, health financing, economic evaluation, implementation science, Indigenous health and the household economic burden of chronic illness.
Throughout his career Stephen has played an active role in advising governments and international agencies. He is a member of the NSW Ministry of Health Child Obesity taskforce and has worked recently with NSW Treasury on developing guidelines for the evaluation of Social Impact Investment
Dr Frank Jones
Frank is a GP in Mandurah and is the current RACGP President. Frank was Chair of the Western Australia Faculty from 2010–2014 and has been a member of the Western Australia Faculty Board since 2004, serving as Deputy Chair in 2006–2010. Frank has been in full time general practice for almost 30 years and was a procedural GP obstetrician for 25 years. Frank is senior partner at the Murray Medical Centre in Mandurah, a large multidisciplinary practice that encourages GPs to extend their patient care skills within the practice, the local community and the regional hospital. Frank has been a GP supervisor for over 15 years and is closely involved with the formal teaching program for registrars. He has previously served as a GP supervisor liaison officer for West Australian General Practice Education and Training (WAGPET). He was chair of the Medical Advisory Committee (MAC) for Murray District Hospital for a number of years, and assumed the MAC chair at Peel Health Campus during the transition to the new health facility. In 2008, he was appointed Adjunct Associate Professor of General Practice at The University of Notre Dame Medical School, Fremantle. He is also a clinical lecturer at University of Western Australia Medical School and has an appointment as a visiting medical officer at Peel Health Campus. Dr Frank Jones is committed to raising the profile of general practice in the Australian community and ensuring the profession remains viable and adequately supported for current and future GPs
Dr Simon Judkins
Dr Simon Judkins has been a doctor for over 20 years, and has worked as an Emergency Physician for fifteen of those. He has worked in Emergency Departments across Melbourne and regional Victoria, holds numerous positions with the Australasian College for Emergency Medicine and the Australian Medical Association, and is a regular contributor to public discussions on issues relating to public hospitals and public health.
Tim Kelsey is senior advisor to the UK Department of Health on technology. He is also a director of Telstra Health, based in Melbourne, Australia and visiting professor, the Institute of Global Health Innovation, Imperial College.
Previously he was National Director for Patients and Information in NHS in England - a role which combined the functions of chief technology and information officer with responsibility for patient and public participation.
He is also an internationally regarded expert in thinking differently about how digital and social media can transform the customer experience in public services. In 2007, he launched NHS Choices, the national online health information service (www.nhs.uk) which now reports around 40 million users per month. In 2014 Tim was named one of the 500 most influential people in UK by Sunday Times.
Before Dr Foster, Tim was a national newspaper journalist and a television reporter. He worked for the Independent and the Sunday Times, as well as Channel 4 and the BBC.
Adjunct Assoc Prof Walter Kmet
Walter Kmet has over 25 years, experience in health care and human services in Australia, South East Asia and the United Kingdom. His experience spans a variety of organisational situations in the private, not for profit, and public sectors. He is currently CEO of WentWest, the Western Sydney Primary Health Network.
He has qualified for a Bachelor of Commerce and Graduate Diploma in Health Services Management from the University of Newcastle, a Master of Business and Technology from the University of NSW, Graduate of the Australian Institute of Company Directors and he has an appointment as Adjunct Associate Professor with Western Sydney University. He is a Board Member of the Australian Healthcare and Hospitals Association, a Member of the NSW Ambulance Advisory Council and Co-Chair of the Western Sydney Partnership Advisory Council.
Dr Andrew Knight
Dr Andrew Knight has been in clinical family practice for 25 years primarily in the Blue Mountains, west of Sydney, and more recently at the Fairfield GP Unit, which is an academic unit of University of New South Wales. He has had senior roles in vocational training of family practitioners and has been involved in quality improvement in Australian primary care since 2002. He is chair of the board of the Nepean Blue Mountains Primary Health Network and is a director of NPS MedicineWise. He is one of the clinical leaders with the Improvement Foundation which conducts the Australian Primary Care Collaboratives program.
Assoc Prof Julie Leask
Julie Leask is a social scientist and Associate Professor in the School of Public Health, University of Sydney. She is also a visiting fellow at National Centre for Immunisation Research and Surveillance where she led the social science unit between 2002 and 2014. Her research and teaching has a particular focus on health risk communication in public and clinical settings.
Dr Robyn Lindner
Dr Robyn Lindner is Client Relationship Manager for Health Technologies at NPS MedicineWise. As part of this role, Robyn recently led the implementation of Choosing Wisely Australia®. This initiative seeks to start a conversation about appropriate healthcare in Australia by challenging the notion that ‘more is always better’ when it comes to healthcare.
Originally trained as a scientist, Robyn has a PhD in biochemistry from the University of Sydney and has worked in academic and clinical research including post doctoral research roles at The University of Wollongong and The Heart Research Institute. Robyn has over 10 years’ experience in the diagnostics sector. Prior to joining NPS MedicineWise, her most recent role was Chief Scientific Officer at Tyrian Diagnostics.
Professor Guy Maddern
Professor Guy Maddern is the RP Jepson Professor of Surgery at the University of Adelaide, Director of Surgery at The Queen Elizabeth Hospital and Royal Adelaide Hospital, and Director of Research at the Basil Hetzel Institute for Translational Health Research at The Queen Elizabeth Hospital. He is the Surgical Director of the Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S) and currently President of the Health Technology Assessment International (HTAi).
Professor Kirsten McCaffery
Kirsten McCaffery is a behavioural scientist and a Professorial Research Fellow at the School of Public Health, University of Sydney. She has an international reputation in the areas of shared decision making, health literacy and screening research and has a special interest in communicating the issue of overdiagnosis and overtreatment to patients and health care providers. She leads the psychosocial research program within the Screening and Test Evaluation Program and is Co-Director and co-founder of the Centre for Medical Psychology and Evidence-based Decision Making (CeMPED). She established the Charles Perkins Centre International Health Literacy Research Network in 2013 which now has over 200 members worldwide. She has over 150 publications and 9 book chapters, and has been awarded over 40 research grants
Sean McClowry is a Partner with Deloitte Digital. His areas of focus include customer strategy, analytics and digital disruption. Sean's has worked in a range of industry verticals including clean energy, financial services, telecommunications, consumer products and health. He is also the founder of Cleanleap – a company that provides clean technology insights in emerging economies.
Professor Michelle Meyer, J.D., Ph.D.
Assistant Professor of Bioethics, Clarkson UniversityDirector of Bioethics Policy, Clarkson–Icahn School of Medicine at Mt. Sinai Bioethics Program.
Michelle Meyer’s writing on research ethics, genomics, and evidence-based policy and practice combines law, philosophy, and behavioral science and has appeared in leading journals of law, science, and bioethics, and in popular media outlets. She earned a Ph.D. in religious studies from the University of Virginia and a J.D. from Harvard Law School.
Dr Yusuf Nagree
Dr Yusuf Nagree is an Emergency Physician and clinical academic based at Fiona Stanley Hospital splitting his time between clinical work on the Emergency Department floor and research. Dr Nagree is also Chair of the Scientific Committee,Chair of the Council of Advocacy and Practice and member of the Quality subcommittee of the Australasian College for Emergency Medicine which is the peak body for Emergency Medicine in Australia & New Zealand
Professor Emeritus Lloyd Sansom AO,
Dip.Pharm,BSc.PhD(Adel),FPS,Hon DSc(Syd), Hon.DHlth(N’cle),Hon DSc(Qld) ,DUniv(Griff), FPS
Professor Sansom was Chair of the PBAC from 2001 to 2012 and from 1991-2000 was the Chair of the Australian Pharmaceutical Advisory Council . He is currently the Special Advisor on the National Medicines Policy Framework to the Department of Health Professor Sansom is the Chair of the Medication Reference Group of the Australian Safety and Quality Commission, He is a director of BellBerry Ltd a not-for-profit organization which promotes the welfare of research participants and the quality of research
Laureate Professor Rob Sanson-Fisher AO
Director of the Health Behaviour Research Group at the University of Newcastle, Australia.
His current research interests include exploring health care provider behaviour and adoption of best evidence practice, and the development, implementation and evaluation of interventions to improve health outcomes for vulnerable population groups.
Adj/Professor John Skerrit
Adjunct Professor John Skerrit joined TGA in May 2012 and is Deputy Secretary for Regulatory Services within the Department of Health, responsible for medicines, medical devices, blood, cells and tissues, chemicals and gene technology. He has a PhD in pharmacology and extensive experience in medical, agricultural and environmental policy, regulation, research management and technology commercialisation.
Mr Andrew Stuart
Andrew Stuart has had an extensive career in the Department of Health spanning Ageing and Aged Care, Population Health, Primary Care and corporate affairs.
Currently, Andrew leads the Health Benefits Group, ensuring existing and innovative medicines and medical devices, procedures and services are accessible to all Australians, used appropriately, at a cost the individual and community can afford.
Andrew’s responsibilities include the Pharmaceutical Benefits Division, the Health Provider Compliance Division and the Medical Benefits Division including Private Health Insurance and the Office of Hearing Services.
In a previous Deputy Secretary role at Health, Andrew led the Department’s Strategic Review and internal change management programme to downsize the Department, realign the corporate functions, reform grant management and promote deregulation.
Ms Diane Walsh
Diane Walsh is the Chair of the NPS MedicineWise Consumer Advisory Group. She is the deputy chair of the Northern Territory Primary Health Network and also the Top End Health Service board. Diane has been an active health consumer advocate at local and national levels for over 15 years. She is now in her twentieth year in the Northern Territory and is based in Darwin.
Dr Lynn Weekes AM
As inaugural CEO of NPS MedicineWise, Lynn has contributed significantly to the development of quality use of medicines (QUM) resources and services for health professionals and consumers in Australia since 1998.
In the 2013 Queen’s Birthday honours Lynn was appointed as a Member of the Order of Australia for her significant service to Australian community health through the promotion of quality use of medicines.
Prior to Lynn’s appointment to NPS MedicineWise, she was executive officer of NSW Therapeutic Assessment Group where she was involved in drug use practice, evaluation and policy. She originally trained as a pharmacist and practised in hospital and research settings.
Ms Wells is the Chief Executive Officer of the Consumers Health Forum of Australia. She is a health service executive with over 25 years’ experience. Ms Wells has held executive positions within government and in national and state non-government organisations, most recently as CEO of the ACT Medicare Local. Throughout her career, she has worked in the health and social care sectors. Ms Wells is the Chair of the COORDINARE (SE NSW Primary Health Network) Community Advisory Committee, as well as a Board Director for COORDINARE, Board Director of the Ozhelp Foundation, Board Director of PainAustralia and a member of the clinical governance committee of Goodwin Aged Care Services. Ms Wells has tertiary qualifications in communications and business. She is a member of both the Australian Institute of Company Directors and the Australian Institute of Management.
Professor Andrew Wilson
Andrew is the Director of the Menzies Centre for Health Policy, University of Sydney and chair of the Pharmaceutical Benefits Advisory Committee. He leads the Australian Prevention Partnership Centre. His research interests concern the application of epidemiology to informing decision making in clinical medicine, public health, and health service policy and planning especially in chronic disease prevention and management.
After completing degrees in science and pharmacy and working as a hospital pharmacist, Michael joined the pharmaceutical industry in 1991. He spent 20 years in the industry in various local and international roles in the health technology assessment (HTA) arena. Since 2011, Michael has been a consultant on biopharmaceutical reimbursement and pricing matters specialising in market access strategies & metrics. He has developed a database of HTA agency submissions and outcomes.
Zhi Yen Wong
Zhi Yen Wong graduated with a pharmacy degree from the Universiti Sains Malaysia (USM) in 2011. He also holds a masters degree in the field of Pharmaceutical Policy from USM in 2014. He is a registered pharmacist with the Malaysia Ministry of Health since 2011. He has been working actively within the MOH regarding the issues related to quality use of generic medicines, impact of academic detailing, cost-effective prescribing, and pharmaceutical pricing policy. He is also an active researcher and involved in several research projects. Up to date, he had published more than ten articles in peer-reviewed reputable journals including Expert Review of Anti-infective Therapy (IF: 3.46) and Health Policy (IF:1.9). He also co-authored few book chapters regarding issues in pharmaceutical pricing and pharmacy practice in low and middle income countries (LMICs) published by Springer and Academic Press (Elsevier). Besides, he is invited reviewer for some peer-reviewed journals including BMC Public Health (IF: 2.3) and The Patient: Patient-Centered Outcomes Research (IF:1.9). Moreover, he managed to secure travel grants to share his research findings in several prestigious conferences including the 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Taipei, Taiwan, and ISPOR 20th Annual International Meeting in Philadelphia, USA.
Do you have questions?
Please contact the NMS secretariat.
Phone: +61 7 3848 2100
Fax: +61 7 3848 2133
Post: Expert Events, PO Box 351, Hamilton Central QLD 4007, Australia